Ahmed, H. et al. (2026) “Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Cirrhosis”, ASIDE Gastroenterology, 2(4), pp. 1–7. doi:10.71079/ASIDE.GI.072726751.